In this study, we evaluated the performance of a humidified nasal high-flow system (Optiflow™, Fisher and Paykel Healthcare) by measuring delivered FiO 2 and airway pressures. Oxygraphy, capnography and measurement of airway pressures were performed through a hypopharyngeal catheter in healthy volunteers receiving Optiflow™ humidified nasal high flow therapy at rest and with exercise. The study was conducted in a non-clinical experimental setting. Ten healthy volunteers completed the study after giving informed written consent. Participants received a delivered oxygen fraction of 0.60 with gas flow rates of 10, 20, 30, 40 and 50 l/minute in random order. FiO 2 , F E O 2 , F E CO 2 and airway pressures were measured. Calculation of FiO 2 from F E O 2 and F E CO 2 was later performed. Calculated FiO 2 approached 0.60 as gas flow rates increased above 30 l/minute during nose breathing at rest. High peak inspiratory flow rates with exercise were associated with increased air entrainment. Hypopharyngeal pressure increased with increasing delivered gas flow rate. At 50 l/minute the system delivered a mean airway pressure of up to 7.1 cmH 2 O. We believe that the high gas flow rates delivered by this system enable an accurate inspired oxygen fraction to be delivered. The positive mean airway pressure created by the high flow increases the efficacy of this system and may serve as a bridge to formal positive pressure systems.
Several devices have recently entered clinical use allowing the delivery of humidified high-flow oxygen via the nasopharynx. Oxygen therapy of this type has several potential advantages over conventional low flow devices and mask oxygen, including minimal variation of the inspired oxygen fraction, humidification and warming, improved comfort 1-3 , the ability to eat, talk and cough easily and the delivery of a positive airway pressure with high gas flow rates (T. David, Canterbury University, New Zealand, personal communication).
Clinically it has been found that exercise capacity is improved in patients with chronic obstructive pulmonary disease while receiving humidified nasal oxygen at 20 l/minute 4 .
One example, the Optiflow™ system, has been developed in New Zealand by Fisher and Paykel Healthcare (East Tamaki, Auckland). The manufacturer states that the system can deliver up to 60 litres per minute of an oxygen/air mixture, at optimal humidity (44 mg water vapour/Lat 37°C) via a soft silicon nasal interface.
This study was undertaken to define the performance of this system by measuring expired oxygen fractions and upper airway pressure in volunteers in an experimental setting.
MATERIALS AND METHODS
The study was approved by the Northern Y Ethics Committee, New Zealand.
Participants
Healthy volunteers over the age of 18 years were invited to participate. Exclusion criteria were: pregnancy, allergy to local anaesthetic agents, upper respiratory tract disease or anatomical deformity and cardiac or respiratory disease precluding heavy exercise. Written, informed consent was obtained from each participant.
Equipment
The system delivers an air/oxygen mixture from a blender (Bird 3800 Microblender) through a variable area flow meter (Key Instruments) to the Optiflow system. This consists of a heated humidifier (Fisher and Paykel Healthcare MR880), heated tubing (Fisher and Paykel Healthcare RT241) and a nasal interface (Fisher and Paykel Healthcare RT034). The nasal interface is made of soft silicon, with a wider bore than traditional nasal cannulae, and is designed specifically to deliver humidified gas. Figure 1 shows the gas delivery and measurement circuit used for this study. A fixed oxygen fraction of 0.6 was used throughout the study. The delivery system was calibrated for flow using a TSI 4040 flow meter (TSI Flow Meters Ltd, Co Laois, Ireland) before passing through the humidifier. The system was also calibrated for delivered oxygen fraction using a direct connection to the gas analysis port of a Datex AS/3 anaesthetic monitor after each change in flow rate.
A 10 Fr PVC catheter was inserted through the nose to the hypopharynx of each participant under topical local anaesthesia (lignocaine spray 10%). Correct placement was confirmed by ensuring the tip was past the oropharynx on visual inspection and by ensuring a stable capnograph trace after connection to the gas analysis port of the Datex AS/3 monitor.
Oxygraphy and capnography of inhaled and exhaled airway gases and airway pressure measurements were obtained by direct connection to the end of the hypopharyngeal catheter. Gas analysis was performed by the Datex AS/3 monitor. This uses sidestream, breath by breath, infrared capnography and paramagnetic oxygraphy. It samples gases at a rate of 200 ml/minute (+/-20 ml/minute). Pharyngeal pressure was measured using a Honeywell precision pressure transducer (PPT -0001 DWW2VA-B, Honeywell International Ltd) with a laptop computer interface.
Peak inspiratory flow rate (PIFR) was measured at rest and with exercise using the Spiroson-AS ultrasonic flow sensor with PC interface (ndd Medizintechnik AG). This has a flow range of up to 16 l/second and an accuracy of +/-3% or 20 ml/second (manufacturer's product information sheet).
Each participant was monitored with electrocardiogram, using the Datex AS/3 monitor.
MEASUREMENT
Hypopharyngeal pressures and fractions of inspiratory O 2 (FiO 2 ), end-tidal O 2 (F E O 2 ), and endtidal CO 2 (F E CO 2 ) were measured from the hypopharyngeal catheter. Each participant, while wearing the nasal interface at rest, was asked to breathe through their nose with their mouth closed. A fixed oxygen fraction of 0.6 at flow rates of 10, 20, 30, 40 and 50 l/minute was delivered in a random order. Recordings were made after a period of stabilisation, ensuring at least four breaths of stable capnography and oxygraphy data. Measurements were then repeated at one minute to ensure a steady state. This process was then repeated for each participant breathing through their mouth for each delivered flow rate.
Respiratory rate and heart rate were monitored throughout. Randomisation of delivered flow rates for each subject was performed using a computer generated randomisation table. Participants were blinded to the flow settings. Participants were then asked to exercise on a stationary bicycle. Participants increased their exercise work rate to achieve a PIFR of greater than 100 l/minute. Heart rate was measured at this point and a stable work rate was achieved by maintaining the heart rate at a constant level. FiO 2 , F E O 2 , F E CO 2 , respiratory rate and heart rate were recorded while wearing the nasal interface and breathing through the nose for each delivered flow rate in descending order from 50 to 10 l/minute.
CALCULATIONS
FiO 2 was calculated from the measured F E CO 2 and F E O 2 by rearranging the alveolar gas equation 5 assuming that: F E O 2 is equal to alveolar oxygen fraction (F A O 2 ), F E CO 2 is equivalent to alveolar carbon dioxide fraction (F A CO 2 ) and the respiratory quotient (RQ) for each participant =0.8 ( Figure 2 ).
STATISTICAL ANALYSIS
Statistical analysis of this hierarchically structured data (different flow rates within each subject) was with linear mixed models. In particular, each subject was assumed to have his or her own relationship between response and flow rate, such that each regression coefficient is a random sample from some population of possible coefficients: the random coefficient mixed model 6 . Plots were used to display the raw data and best fitting models.
The usual residual and other diagnostics were performed. Statistical significance was assumed at P <0.05.
RESULTS
Ten subjects (eight men and two women) completed the study (Table 1 ) Mean PIFR at rest was 27.9 (SD 9.23) l/minute and with exercise 119.9 (SD 20.04) l/ minute. All but one of the participants (who achieved greater than 90 l/minute) were able to generate a PIFR of greater than 100 l/minute. Table 2 gives the mean values for F E O 2 , F E CO 2 and calculated FiO 2 for all three breathing patterns versus delivered flow rates. For calculated FiO 2 (Figure 3 ) there is a significant upward trend with increasing flow rate (P <0.001) for all breathing patterns. Calculated FiO 2 is highest, for all delivered gas flow rates, when breathing at rest through the nose, and lowest when exercising to a PIFR of >90 l/minute. There is a significant difference between the calculated FiO 2 for each of the three breathing patterns (P <0.001).
For respiratory rate (Figure 4 ), there are significant differences between the three breathing patterns (P <0.001). Respiratory rate is highest with exercise and lowest when breathing at rest with the mouth closed. There is also a downward trend of respiratory rate plotted against delivered gas flow rate for all three breathing patterns; this is not statistically significant (P=0.15).
Equation 2 For F E CO 2 (Figure 5 ), there are again significant differences between the three breathing patterns (P <0.001), highest with exercise and lowest when breathing at rest with the mouth open. There is no change seen with increasing flow rate. Figure 6 is a plot of upper airway pressure versus time for one participant breathing 10 and 40 l/minute through the nose and 40 l/minute with the mouth open. Peak pressures are noticeably higher at the higher delivered gas flow rate and with breathing with the mouth closed rather than with the mouth open.
For mean upper airway pressure ( Figure 7 ) both slope (P <0.001) and means of individual data (P <0.001) with mouth open and closed showed differences; with mouth closed in particular showing increasing pressure with increasing delivered gas flow rate. Here there is almost a linear response in mean upper airway pressures with increasing delivered gas flow rates above 30 l/minute; at 30 l/ minute the mean upper airway pressure approaches 3 cmH 2 O, at 40 l/minute it is approximately 4 cmH 2 O and at 50 l/minute the mean upper airway pressure is approximately 5 cmH 2 O.
DISCUSSION
This study evaluates a high-flow nasal oxygen delivery system in healthy volunteers. We found that the calculated FiO 2 approached the prescribed FiO 2 when the delivered gas flow rates were greater than participant PIFR. Furthermore, when the subjects breathed with their mouth closed, the system delivered a clinically relevant mean positive airway pressure which was directly proportional to delivered gas flow rates.
The method of pharyngeal oxygraphy and capnography is well described and has been found to be reliable [7] [8] [9] [10] [11] [12] [13] [14] . Two other papers have also described this method to measure upper airway pressures 15, 16 and have had similar findings to this study. Tracheal sampling via a cricothyroid puncture has been used in the assessment of FiO 2 17 but this is invasive and at least three deaths have been attributed to this technique 18 . Hypopharyngeal sampling compares favourably to tracheal sampling 9 , is less invasive and is better tolerated by the awake subject.
The FiO 2 was calculated by rearrangement of the alveolar gas equation (Figure 2) 7, 8 . FiO 2 was measured directly, but concerns regarding gas streaming in the upper airway causing incomplete mixing in the hypopharynx have previously been raised and this has been reason for criticism of a recent paper 19, 20 . The Riley version of the equation was used in this study to allow for the difference in inspired and expired volumes 5 . Several assumptions need to be made to use this method, which results in a derivative of the F E O 2 , which is, physiologically, the most relevant indicator of alveolar oxygen fraction (F A O 2 ).
We used a single oxygen fraction of 0.6 in this study. This was chosen to be high enough to show significant differences with each flow rate while minimising potential adverse effects from high concentration oxygen, in particular, absorption atelectasis.
We observed a constant, small but statistically significant difference for calculated FiO 2 between nose breathing and mouth breathing at rest (Figure 3) . There are three possible reasons for this observation. The first is an increase in air entrainment caused by the participant's inspiratory flow when the mouth is open. This was also described by Lomholt in 1968 2 . If this were the only cause, we would have expected this effect to decrease with increasing delivered flow rates causing the two curves to converge; this wasn't seen in this study.
A second possible cause is sampling error; the Datex AS3 samples from the pharyngeal catheter at a rate of approximately 200 ml/minute. It is possible that this causes entrainment of air into the sampling line when the mouth is open. This phenomenon could also explain the similar difference seen in F E CO 2 between nose and mouth breathing ( Figure 5 ).
Third, a venturi effect might explain the difference between mouth and nose breathing. When the mouth is open, increased delivered flow rates are associated with increasing air entrainment. The system with the mouth closed is sealed enough to prevent this effect.
It is possible that all of these effects are present and have a net effect which results in a relatively constant difference in expired oxygen between mouth and nose breathing, as delivered flow rate increases.
We used exercise to simulate respiratory distress. flow rates using a model 21 or have asked participants to increase their respiratory rate voluntarily using a metronome 9, 11 . The high PIFR with exercise attained in this study was associated with lower calculated FiO 2 than those measured at rest (Figure 3 ). Furthermore the curves are more linear with exercise. It is likely that the gas flow rates used in this study are not high enough to minimise air entrainment when the participant is breathing with a PIFR in excess of 90 l/minute. It is not known how clinically relevant these findings are as we were unable to find any published data describing the breathing pattern, particularly peak inspiratory flow rates, in patients with acute respiratory disease. Positive end-expiratory pressure is an important treatment for a number of acute hypoxic diseases. The high flows delivered by the studied system act as a resistance to exhalation and deliver a clinically significant mean airway pressure when the mouth is closed. The positive mean airway pressures in this study were similar to end-expiratory oral pressures measured in volunteers using the same system and wearing the same nasal interface in an unpublished study from Canterbury University, New Zealand (T. David, personal communication). The positive airway pressure delivered by such devices may explain part of their efficacy in treating hypoxemia.
Previous studies have simulated increased inspiratory
A third proposed benefit of this type of system is the ability to deliver warmed humidified gas to the nasopharynx and upper airway. Mucosal function is impaired above and below the optimum level of temperature and humidity; i.e. core temperature and 100% relative humidity 22 . The humidification of delivered oxygen has been found to be beneficial for patients in other studies 23, 24 . We chose to focus on the delivery of FiO 2 and positive airway pressure and we await further humidity data with anticipation.
Respiratory rate was not a primary measurement in this study. However, the data suggest that there could be a decrease in respiratory rate with an increase in delivered gas flow rate for all breathing patterns (Figure 4 ). Another study comparing 15 l/ minute of delivered oxygen through a Hudson mask and nasal cannula found that respiratory rate was lower when using the nasal cannula 25 . This might be followed by a decrease in minute volume but F E CO 2 measurements in our study do not support this in healthy volunteers. It is likely that tidal volume is increased in proportion to the decrease in respiratory rate. It is also likely that the high flows delivered by this system washout anatomical dead space, contributing to the effect seen on F E CO 2 . Further work on this is needed in patients with respiratory failure.
CONCLUSION
The studied oxygen delivery system delivers a prescribed FiO 2 at delivered gas flow rates greater than peak inspiratory flow rate whether or not the wearer is breathing through their mouth or nose. However the system could not be considered a fixed oxygen delivery system as described by Leigh 26 as accuracy of the system depends on the wearer's breathing pattern.
With the mouth closed, the system delivers a clinically relevant positive airway pressure proportional to the delivered gas flow rate.
